Actively Recruiting
Stem Cell Transplantation Using AlphaBeta T-Cell and B-Cell Depletion with Personalized ATG Dosing for Patients Under 25 with Blood Cancers
Led by Medical College of Wisconsin · Updated on 2026-05-13
40
Participants Needed
1
Research Sites
261 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a new approach for patients with blood cancers who receive stem cell transplants from unrelated or partially matched donors. This study focuses on using a special device called CliniMACS to remove specific immune cells alphabeta T cells and CD19 B cells from the donors blood stem cells. The goal is to study how this method, combined with personalized dosing of a drug called ATG based on immune cell levels, affects engraftment, graft-versus-host disease GVHD, and disease-free survival. Participants will undergo a stem cell transplant where donor cells are processed with the CliniMACS device to deplete certain immune cells. The treatment includes individualized dosing of ATG tailored to each patients immune status. This is a single-arm pilot study, meaning all participants receive the same treatment approach. Donors will undergo mobilization and stem cell collection through peripheral blood. The study will follow patients over different timeframes to monitor outcomes and safety. During the study, participants will be closely monitored for acute and chronic GVHD, platelet engraftment, viral infections, disease relapse, and treatment-related mortality. Various assessments will take place over 1 to 5 years after the transplant. Researchers will track survival rates and disease status to understand the impact of this transplant method. The total participation time varies, with key outcomes evaluated at 1 year and extended follow-up for safety and disease control.
CONDITIONS
Brief Title
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Research Team
M
Meredith Beversdorf, RN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here